4.6 Review

The direct correlation between microbiota and SARS-CoV-2 infectious disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications

Naoyoshi Nagata et al.

Summary: This study investigates the interrelationships among gut microbes, metabolites, and cytokines in COVID-19 and its complications, and validates the results with follow-up data. The results show multiple correlations between COVID-19-related microbes, gut metabolites, and inflammatory cytokine dynamics, especially in severe disease and pneumonia. The study also confirms the concordance of altered metabolites in COVID-19 with their corresponding microbial functional genes.

GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19

Fen Zhang et al.

Summary: Patients with COVID-19 displayed impaired capacity for SCFA and L-isoleucine biosynthesis in their gut microbiome, even after disease resolution. These microbial dysfunctions were associated with host immune response, highlighting the importance of gut microbial functions in the pathogenesis and outcome of SARS-CoV-2 infection.

GASTROENTEROLOGY (2022)

Letter Medicine, General & Internal

COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view

Antonio Vitiello et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Review Oncology

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies

Yuting Lu et al.

Summary: The gut microbiota play a crucial role in modulating antitumor immunity and enhancing the efficacy of cancer immunotherapies, particularly immune checkpoint inhibitors. Metabolites are a key mechanism through which the gut microbiota impact antitumor immune responses.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Review Medicine, General & Internal

Advances in the Omicron variant development

Antonio Vitiello et al.

Summary: This review provides an overview of the molecular profile, epidemiology, transmissibility, impact on vaccines, and pharmacological agents related to the Omicron variant of SARS-CoV-2. Omicron has multiple mutations, including changes in the spike protein, which contribute to its high transmissibility and potential immune escape. Current vaccination provides limited protection against Omicron, while booster doses offer significant protection against mild illness. New oral antiviral agents are emerging as important alternatives for treatment. Further research is needed to determine the infectiousness of Omicron and the effectiveness of available vaccines, monoclonal antibodies, and antiviral drugs.

JOURNAL OF INTERNAL MEDICINE (2022)

Article Nutrition & Dietetics

Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans

Anthony A. Xu et al.

Summary: This study investigated the impact of dietary fatty acid intake on gut microbiota composition and structure. The results showed that different types of fatty acid intake were associated with significant differences in the β diversity of gut bacteria. Specific bacteria such as Sutterella, Tyzzerella, and Fusobacterium were found to have a significant correlation with fatty acid intake.

NUTRIENTS (2022)

Article Multidisciplinary Sciences

Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes

Shanlin Ke et al.

Summary: This study analyzed the gut microbiome of COVID-19 patients using metagenome sequencing and found a significant reduction in strain richness for many species. The gut microbiome can accurately identify COVID-19 cases and predict disease progression. The study also identified microbial strains with a potential causal role in the clinical manifestations of COVID-19 and revealed their functional pathways.

NATURE COMMUNICATIONS (2022)

Letter Medicine, General & Internal

Remdesivir and COVID-19

Francesco Ferrara et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2021)

Review Pharmacology & Pharmacy

Drugs acting on the renin-angiotensin system and SARS-CoV-2

Antonio Vitiello et al.

Summary: This article discusses the potential of therapeutic agents acting on the renin-angiotensin system (RAS) to modulate the concentration of ACE-2 and combat SARS-CoV-2 infection. It also highlights the possible negative effects of the ACE/Ang-II/AT-1r axis and the potential beneficial role of the ACE-2/Ang 1-7/MasR axis in ARDS caused by SARS-CoV-2, suggesting the possibility of targeting various RAS components with drug treatments to improve clinical outcomes.

DRUG DISCOVERY TODAY (2021)

Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.
Review Virology

Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19

Jiezhong Chen et al.

Summary: Covid-19, caused by SARS-CoV-2 infection, is a global pandemic with potential fatal outcomes for severe cases. The dysregulation of gut microbiota plays a crucial role in the pathogenesis of Covid-19, affecting the prevention and treatment of severe cases. Various risk factors could lead to severe Covid-19, and maintaining a diverse gut microbiota and supplementing with commensal microbial metabolites may be beneficial in preventing and treating severe cases.

REVIEWS IN MEDICAL VIROLOGY (2021)

Article Medicine, Research & Experimental

Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19

Antonio Vitiello et al.

Summary: In the absence of effective antiviral drugs or vaccines against SARS-CoV-2, it is crucial to explore new treatment options from existing drugs on the market. Recent hypotheses suggest that a combination of AT-1 receptor antagonists and neprilysin inhibitors may provide clinical benefits to patients with severe COVID-19 infection and cardiac involvement.

MEDICAL HYPOTHESES (2021)

Article Multidisciplinary Sciences

16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

Antonio Mazzarelli et al.

Summary: COVID-19 patients show altered gut microbiota composition, with decreased microbial richness in ICU patients and increased Proteobacteria in infectious disease wards patients compared to controls.

PLOS ONE (2021)

Review Medicine, General & Internal

Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review

Hailay Abrha Gesesew et al.

Summary: This study aimed to provide evidence on risk factors for COVID-19 transmission, disease severity, and deaths in Africa. Higher infection rates in Africa are associated with factors such as high population density, urbanization, transport connectivity, tourism volume, international trade, economic and political openness, and limited access to healthcare. Demographic, institutional, ecological, health system, and politico-economic factors were found to influence the spectrum of COVID-19 infection, severity, and death, highlighting the importance of multidisciplinary approaches for effective prevention strategies.

BMJ OPEN (2021)

Article Biology

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults

Rong Xu et al.

Summary: This study conducted longitudinal analyses of throat and anal microbiomes in 35 COVID-19 patients and 19 healthy controls. Results showed lower bacterial diversity in COVID-19 patients, but observed a synchronous restoration of upper respiratory and gut microbiomes in some mild patients.

COMMUNICATIONS BIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Scientific Hypothesis for Treatment of COVID-19′s Lung Lesions by Adjusting ACE/ACE2 Imbalance

F. Ferrara et al.

Summary: The global COVID-19 pandemic, caused by the new Coronavirus SARS-CoV-2, has led to millions of deaths worldwide. The ACE-2 protein plays a crucial role in the infection process, making it a potential target for pharmacological intervention in treating COVID-19. Understanding the interactions between RAS, ACE-2, and ACE/ACE2 balance could provide valuable insights for developing effective treatments for the virus.

CARDIOVASCULAR TOXICOLOGY (2021)

Review Genetics & Heredity

Gut Microbiome Alterations in COVID-19

Tao Zuo et al.

Summary: The gut microbiome in patients with COVID-19 undergoes significant alterations, including weakening of the microbial ecological network, decreased diversity, enrichment of opportunistic bacteria, fungi, and viruses, as well as reduction in abundance of symbiotic bacteria and bacteriophages. These changes are associated with disease severity and persistence even after recovery, hindering the reassembly of the gut microbiome. Further research is needed to fully understand the role of the gut microbiome in host immunity against SARS-CoV-2 infection and the long-term effects of COVID-19 on the gut microbiome.

GENOMICS PROTEOMICS & BIOINFORMATICS (2021)

Article Biochemistry & Molecular Biology

Mucins and the Microbiome

Gunnar C. Hansson

Annual Review of Biochemistry (2020)

Editorial Material Microbiology

Moving from probiotics to precision probiotics

Patrick Veiga et al.

NATURE MICROBIOLOGY (2020)

Review Microbiology

Immunoglobulin A and the microbiome

Yi Yang et al.

CURRENT OPINION IN MICROBIOLOGY (2020)

Article Chemistry, Medicinal

The Human Microbiota, Infectious Disease, and Global Health: Challenges and Opportunities

Abraham J. Waldman et al.

ACS INFECTIOUS DISEASES (2018)

Review Biochemistry & Molecular Biology

Current understanding of the human microbiome

Jack A. Gilbert et al.

NATURE MEDICINE (2018)

Article Microbiology

Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model

Andrew J. Hryckowian et al.

NATURE MICROBIOLOGY (2018)

Review Gastroenterology & Hepatology

Physiological Role of Gut Microbiota for Maintaining Human Health

Akira Andoh

DIGESTION (2016)

Article Gastroenterology & Hepatology

Current Understanding of Dysbiosis in Disease in Human and Animal Models

Arianna K. DeGruttola et al.

INFLAMMATORY BOWEL DISEASES (2016)

Review Biochemistry & Molecular Biology

Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology

Patricia Ojeda et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)

Review Gastroenterology & Hepatology

Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate

Antonella Gallo et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Medicine, General & Internal

Probiotics for preventing acute upper respiratory tract infections

Qiukui Hao et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)

Review Biochemistry & Molecular Biology

Role of the Microbiota in Immunity and Inflammation

Yasmine Belkaid et al.

Review Biochemical Research Methods

Rational identification of diet-derived postbiotics for improving intestinal microbiota function

Cory Klemashevich et al.

CURRENT OPINION IN BIOTECHNOLOGY (2014)

Article Biotechnology & Applied Microbiology

Towards a better understanding of Lactobacillus rhamnosus GG - host interactions

Marijke E. Segers et al.

MICROBIAL CELL FACTORIES (2014)

Article Multidisciplinary Sciences

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Yukihiro Furusawa et al.

NATURE (2013)

Article Medicine, General & Internal

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

Els van Nood et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Allergy

Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses

Matthew T. Lotz et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2012)

Review Immunology

Pulmonary-intestinal cross-talk in mucosal inflammatory disease

S. Keely et al.

MUCOSAL IMMUNOLOGY (2012)

Review Nutrition & Dietetics

Defining the human microbiome

Luke K. Ursell et al.

NUTRITION REVIEWS (2012)

Review Gastroenterology & Hepatology

The role of gut microbiota in immune homeostasis and autoimmunity

Hsin-Jung Wu et al.

GUT MICROBES (2012)

Review Immunology

Epithelial antimicrobial defence of the skin and intestine

Richard L. Gallo et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Microbiology

Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis

Charles L. Bevins et al.

NATURE REVIEWS MICROBIOLOGY (2011)

Article Multidisciplinary Sciences

Symbiotic bacteria direct expression of an intestinal bactericidal lectin

Heather L. Cash et al.

SCIENCE (2006)

Article Immunology

Innate secretory antibodies protect against natural Salmonella typhimurium infection

OLC Wijburg et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Review Immunology

Mammalian defensins in the antimicrobial immune response

ME Selsted et al.

NATURE IMMUNOLOGY (2005)

Article Gastroenterology & Hepatology

Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome

A Yazar et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)